Pietro Genovese

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Ospedale San Raffaele S.r.l., Sangamo Therapeutics, Inc., Fondazione Telethon. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pietro Genovese. Retrieved from https://idiyas.com/inventor/pietro-genovese

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 267(Granted Patents)

Location History:

Messina, IT (2015)
Milan, IT (2018 - 2024)

Company Filing History:

7 out of 55

Ospedale San Raffaele S.r.l.

patents

5 out of 153

Sangamo Therapeutics, Inc.

Editas Medicine, Inc.

patents

5. 1 out of 9

Fondazione Telethon Ets

patents

6. 1 out of 160

Sangamo Biosciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12558435 - TRANSIENT INHIBITION OF p53 IN GENE THERAPY (2026-02-24),

2. 12485187 - METHOD FOR IMPROVING RETROVIRAL TRANSDUCTION AND GENE EDITING IN HEMATOPOIETIC STEM CELLS USING CLYCLOSPORIN H AND UM171 (2025-12-02),

3. 12214055 - Systems and methods for treating hyper-igm syndrome (2025-02-04),

4. 11964027 - Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH) (2024-04-23),

5. 11439666 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2022-09-13),

6. 10918668 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2021-02-16),

7. 10155011 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2018-12-18),

8. 10117899 - Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells (2018-11-06),

9. 9937207 - Targeted disruption of T cell receptor genes using talens (2018-04-10),

10. 8956828 - Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases (2015-02-17),

Title: The Innovative Mind of Pietro Genovese

Introduction:

Pietro Genovese, a visionary inventor hailing from Milan, Italy, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Pietro Genovese's latest patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable transportation methods.

Career Highlights:

With a career spanning over two decades, Pietro Genovese has established himself as a leading figure in the tech industry, with a strong focus on creating solutions that positively impact society and the environment.

Collaborations:

Throughout his career, Pietro Genovese has collaborated with top research institutions, leading universities, and innovative companies to bring his ideas to life and push the boundaries of technological innovation.

Conclusion:

In conclusion, Pietro Genovese's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the field of inventions. His work continues to inspire and shape the world we live in today.

Profile summary based on public USPTO records.